Skip to main content
. Author manuscript; available in PMC: 2023 Jun 9.
Published in final edited form as: Pain Med. 2017 Mar 1;18(3):454–467. doi: 10.1093/pm/pnw140

Table 1.

30-Item Survey Organized into 10 Content Domains

PARIHS Domains Survey Content Domains Associated Questions
Evidence 1. Background information 1-8
2. Opioid and benzodiazepine prescribing practices 9-13
3. Knowledge of pain management and insomnia clinical practice guidelines 14-15
4. Level of agreement with clinical practice guidelines that caution against concurrent prescribing of opioids and benzodiazepines among high risk groups 16
5. Beliefs that contribute to opioid and benzodiazepine co-prescribing 17-18
6. Beliefs about discontinuing co-prescribed opioids and benzodiazepines 19-20
7. Typical outcomes for patients co-prescribed opioids and benzodiazepines 21-25
Context 8. Team support/encouragement around reducing opioid and benzodiazepine co-prescribing 26
9. Resources that would support efforts to discontinue or reduce co-prescribing of opioids and benzodiazepines 27-29
10. Potential benefits of and barriers to using medication alerts 30